Total Payments
$1,449
2024 Payments
$29.49
Companies
17
Transactions
48
Medicare Patients
1,324
Medicare Billing
$203,532
Payment Breakdown by Category
Food & Beverage$1,128 (77.8%)
Education$321.27 (22.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,128 | 46 | 77.8% |
| Education | $321.27 | 2 | 22.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith+Nephew, Inc. | $392.69 | 6 | $0 (2023) |
| Stryker Corporation | $249.96 | 6 | $0 (2019) |
| Optinose US, Inc. | $192.36 | 14 | $0 (2023) |
| GENZYME CORPORATION | $179.03 | 4 | $0 (2024) |
| Intersect ENT, Inc. | $147.03 | 1 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $58.49 | 3 | $0 (2023) |
| Amneal Pharmaceuticals LLC | $29.75 | 2 | $0 (2021) |
| Lilly USA, LLC | $26.33 | 1 | $0 (2022) |
| Amgen Inc. | $26.25 | 2 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $25.44 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.49 | 2 | GENZYME CORPORATION ($14.98) |
| 2023 | $306.72 | 10 | GENZYME CORPORATION ($152.14) |
| 2022 | $160.39 | 10 | OptiNose US, Inc. ($55.87) |
| 2021 | $173.30 | 12 | Optinose US, Inc. ($66.75) |
| 2020 | $382.01 | 7 | Smith+Nephew, Inc. ($353.10) |
| 2019 | $396.99 | 7 | Stryker Corporation ($249.96) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Inflammation | ||||||
| 04/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Immunology | ||||||
| 11/29/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/18/2023 | Smith+Nephew, Inc. | HALO (Device), TULA | Food and Beverage | In-kind items and services | $39.59 | General |
| Category: Sports Med Resection | ||||||
| 07/11/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/21/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/14/2023 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: EAR NOSE & THROAT | ||||||
| 05/18/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/26/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Immunology | ||||||
| 03/08/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $138.16 | General |
| Category: Immunology | ||||||
| 02/16/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/08/2023 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/08/2022 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Inflammation | ||||||
| 11/09/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/18/2022 | Aroa Biosurgery Incorporated | — | Food and Beverage | Cash or cash equivalent | $21.09 | General |
| 06/30/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: IMMUNOLOGY | ||||||
| 06/01/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/25/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/25/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Immunology | ||||||
| 04/13/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/24/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Immunology | ||||||
| 02/16/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/18/2021 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $11.55 | General |
| 10/11/2021 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $13.89 | General |
| 07/26/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 429 | 636 | $229,134 | $71,726 |
| 2022 | 10 | 408 | 613 | $217,955 | $68,096 |
| 2021 | 6 | 352 | 446 | $130,788 | $46,886 |
| 2020 | 7 | 135 | 154 | $66,016 | $16,824 |
Total Patients
1,324
Total Services
1,849
Medicare Billing
$203,532
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2023 | 95 | 126 | $59,850 | $16,629 | 27.8% |
| 31574 | Injection of substance to augment voice box using an endoscope | Office | 2023 | 13 | 18 | $65,000 | $15,281 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 143 | $29,315 | $13,549 | 46.2% |
| 92612 | Evaluation and recording of swallowing using an endoscope | Office | 2023 | 44 | 47 | $19,834 | $6,641 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $10,920 | $5,170 | 47.3% |
| L8607 | Injectable bulking agent for vocal cord medialization, 0.1 ml, includes shipping and necessary supplies | Office | 2023 | 11 | 94 | $9,400 | $3,680 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 50 | $8,750 | $3,417 | 39.0% |
| 74230 | Imaging for evaluation of swallowing function | Office | 2023 | 27 | 27 | $9,450 | $2,487 | 26.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $5,550 | $2,407 | 43.4% |
| 92613 | Evaluation, recording, and interpretation of swallowing using an endoscope | Office | 2023 | 44 | 47 | $4,465 | $1,271 | 28.5% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 11 | 12 | $6,600 | $1,194 | 18.1% |
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2022 | 87 | 136 | $64,600 | $17,609 | 27.3% |
| 31574 | Injection of substance to augment voice box using an endoscope | Office | 2022 | 12 | 15 | $60,000 | $14,328 | 23.9% |
| 92612 | Evaluation and recording of swallowing using an endoscope | Office | 2022 | 53 | 56 | $23,632 | $8,225 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 80 | $16,400 | $7,786 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $13,033 | $6,659 | 51.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 78 | $13,650 | $5,329 | 39.0% |
| L8607 | Injectable bulking agent for vocal cord medialization, 0.1 ml, includes shipping and necessary supplies | Office | 2022 | 11 | 114 | $11,400 | $4,127 | 36.2% |
| 92613 | Evaluation, recording, and interpretation of swallowing using an endoscope | Office | 2022 | 53 | 56 | $5,320 | $1,587 | 29.8% |
| 70486 | Ct scan of face without contrast | Office | 2022 | 14 | 14 | $7,700 | $1,417 | 18.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,220 | $1,030 | 46.4% |
| 31579 | Examination to assess movement of vocal cord flaps using an endoscope | Office | 2021 | 79 | 114 | $54,150 | $15,664 | 28.9% |
| 92612 | Evaluation and recording of swallowing using an endoscope | Office | 2021 | 57 | 70 | $29,540 | $10,413 | 35.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 97 | $20,140 | $9,210 | 45.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 53 | 53 | $13,118 | $6,723 | 51.2% |
About Dr. Ryan Stephenson, MD
Dr. Ryan Stephenson, MD is a Otolaryngology healthcare provider based in Provo, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2014. The National Provider Identifier (NPI) number assigned to this provider is 1760800353.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Stephenson, MD has received a total of $1,449 in payments from pharmaceutical and medical device companies, with $29.49 received in 2024. These payments were reported across 48 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,128).
As a Medicare-enrolled provider, Stephenson has provided services to 1,324 Medicare beneficiaries, totaling 1,849 services with total Medicare billing of $203,532. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Provo, UT
- Active Since 04/01/2014
- Last Updated 03/03/2022
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1760800353
Products in Payments
- PROCISE MAX (Device) $321.27
- DUPIXENT (Biological) $237.52
- Xhance (Drug) $192.36
- PROPEL (Device) $147.03
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $129.80
- NSE - CUTTING ACCESSORIES (Device) $80.99
- HALO (Device) $39.59
- UNIVERSAL MANDIBLE (Device) $39.17
- UNITHROID (Drug) $29.75
- TALTZ (Drug) $26.33
- Tirosint (Drug) $23.53
- TULA System (Device) $19.05
- VIVAER STYLUS (Device) $17.21
- AUVI-Q (Drug) $16.17
- TEPEZZA (Drug) $16.08
- NUCALA (Biological) $15.05
- TAVNEOS (Drug) $14.51
- PROCISE Tonsil (Device) $12.78
- Enbrel (Biological) $11.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Provo
Jordan Schramm, Md, MD
Otolaryngology — Payments: $107,510
Otolaryngology $107,510
Dr. Seth Riddle, M.d, M.D
Otolaryngology — Payments: $10,259
Otolaryngology $10,259
Scott Shipley, Md, MD
Otolaryngology — Payments: $7,930
Otolaryngology $7,930
Kirt Beus, Md, MD
Otolaryngology — Payments: $2,960
Otolaryngology $2,960
Matthew Money, Md, MD
Otolaryngology — Payments: $1,900
Otolaryngology $1,900
Dr. Kipp Robins, Md, MD
Otolaryngology — Payments: $1,302
Otolaryngology $1,302